SUFU 2021: Short-Term Outcomes of Periurethral Injection of Polyacrylamide Hydrogel (Bulkamid®) for Stress Urinary Incontinence with Intrinsic Sphincter Deficiency, Post Mid-Urethral Sling, and Post Mesh Sling Excision

(UroToday.com) Polyacrylamide Hydrogel (PAHG), Bulkamid®, is a non-particle-based urethral bulking agent that has demonstrated longer-term durability compared to other bulking agents. This study examined short-term outcomes of PAGH injection in an initial cohort, specifically looking at women with intrinsic sphincter deficiency (ISD), post mesh sling excision, and/or refractory stress urinary incontinence (SUI).